Koyfin Home > Directory > Health Care > Abeona Therapeutics > Long-Term Debt / Capital

Abeona Therapeutics Long-Term Debt / Capital Chart (ABEO)

Abeona Therapeutics annual/quarterly Long-Term Debt / Capital from 2010 to 2020.
  • Abeona Therapeutics Long-Term Debt / Capital for the quarter ending June 06, 2020 was $4m a -40.47% decrease of -2m year over year
  • Abeona Therapeutics Long-Term Debt / Capital for the last 12 months ending June 06, 2020 was $4m a -40.47% decrease of -2m year over year
Other Ratios Metrics:
  • Abeona Therapeutics Total Debt / Capital for the quarter ending December 12, 2014 was $8m a -1,061.80% decrease of -81m year over year
  • Abeona Therapeutics Other Liabilities for the quarter ending December 12, 2017 was $3m a -14.77% decrease of 0m year over year
  • Abeona Therapeutics Total Debt / Equity for the quarter ending December 12, 2014 was $8m a -36,027.59% decrease of -2,992m year over year
View Chart On Koyfin

Quarterly ABEO Long-Term Debt / Capital Data

06/2020$4m
03/2020$4m
12/2019$3m
09/2019$6m
06/2019$6m
03/2019$5m
06/2011$-23m
06/2010$-44m
03/2010$-37m

Annual ABEO Long-Term Debt / Capital Data

2019$3m